Robert Wood Johnson University Hospital Somerset, located in Somerville, New Jersey, is a nationally accredited, 355-bed regional medical center providing a variety of comprehensive emergency, medical/surgical and rehabilitative services to Central New Jersey residents.

There are 355 beds in Robert Wood Johnson University Hospital Somerset.

During the past decade, Robert Wood Johnson University Hospital Somerset conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 46 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 27 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Robert Wood Johnson University Hospital Somerset" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "Alliance for Clinical Trials in Oncology" with 19 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "Rutgers, The State University of New Jersey" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Robert Wood Johnson University Hospital Somerset" #1 collaborator was "National Cancer Institute (NCI)" with 70 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Robert Wood Johnson University Hospital Somerset" are "Breast Cancer" (13 trials), "Prostate Cancer" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Invasive Breast Carcinoma" (7 trials) and "Lung Cancer" (6 trials). Many other conditions were trialed in "Robert Wood Johnson University Hospital Somerset" in a lesser frequency.

Most popular intervention types in "Robert Wood Johnson University Hospital Somerset" are "Drug" (90 trials), "Other" (65 trials), "Biological" (28 trials), "Radiation" (27 trials) and "Procedure" (22 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Quality-of-Life Assessment" (22 trials), "Questionnaire Administration" (16 trials), "Paclitaxel" (14 trials) and "Docetaxel" (11 trials). Other intervention names were less common.

The vast majority of trials in "Robert Wood Johnson University Hospital Somerset" are 84 trials for "All" genders, 24 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Robert Wood Johnson University Hospital Somerset". undefined are not yet recruiting, 29 are recruiting, 47 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Robert Wood Johnson University Hospital Somerset, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Robert Wood Johnson University Hospital Somerset, 3 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".

Robert Wood Johnson University Hospital Somerset has several departments that took part in Clinical trials: "Steeplechase Cancer Center" - 5 trials